Sygehus Soenderjylland Soenderborg — Clinical Trial Site

33 Registered trials

17 Currently recruiting

Organisation

Sygehus Soenderjylland Soenderborg

Location

Soenderborg, Denmark

Identifier

ORG-100030268

Address

Sydvang 1, 6400, Denmark

Departments

045001:Onkologisk Ambulatorium
Afdeling for hjertesygdomme
Anaesthesiology
Børne og Unge, Sygehus Sønderjylland
Cardiology
Deparment of Oncology
Department of Anaesthesia
Department of Anesthesiology and Intensive Care
Department of Cardiology
Department of Clinical Oncology
Department of Oncology
Department of orthopedics
Hjertemedicinsk Klinik
Hjertesygdomme
Internal Medicine
Kræftambulatoriet
Medicine
N/A
Oncology
Oncology, Centre for Cancer and Organ Diseases/Afd 5073
Onkologisk afdeling
Onkologisk Ambulatorium
Sygehus Sonderjylland i Aabenraa
Sygehus Sønderjylland - Afd. for Hjertesygdomme, Ambulatorium Område 4

Clinical trials at this site (33)

Search interface

Continuous versus intermittent intravenous furosemide treatment in patients hospitalised with acute heart failure Pending

2025-523589-26-00 Acute heart failure with volume overload 6
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Acute critical illness requiring intensive care unit ad 6 2025-06-26
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A Study to compare RLY-2608 + Fulvestrant with Capivasertib + Fulvestrant in people with PIK3CA-mutated, hormone-receptor positive, HER2-neg… Recruiting

2025-523083-21-00 PIK3CA-mutant Hormone Receptor Positive, Human Epiderma 5 2025-12-08
Remifentanil versus rocuronium for optimizing video laryngoscopy assisted tracheal intubation in patients undergoing general anaesthesia - a… Recruiting

2025-521405-40-01 Adult patients undergoing tracheal intubation using vid 11 2025-11-12
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i… Recruiting

2024-518365-10-00 Previously Untreated Advanced or Metastatic Non-Squamou 5 2025-10-28
Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial Recruiting

2022-502770-16-00 GERD, Cows' milk allergy 11 2025-10-27
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio… Recruiting

2024-519525-38-00 Heart failure 5 2025-08-22
A Study of Nivolumab + Relatlimab Fixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy in Participants with Non-s… Recruiting

2024-513682-40-01 Non-squamous (NSQ), Stage IV or Recurrent Non-small Cel 5 2025-07-04
Comparing the Efficacy and Safety of Aspirin Alone versus Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (… Recruiting

2024-517229-18-00 Non-ST-Elevation Myocardial Infarction (NSTEMI) 11 2025-04-30
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: a multicenter randomized clinical trial (MONITOR-RCT) Recruiting

2023-508591-11-00 Metastatic breast cancer 5 2025-02-25
ALEXIS Recruiting

2023-510042-24-01 osteoporosis 6 2025-01-30
Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p… Recruiting

2022-502500-75-00 Atrial fibrillation 6 2024-01-30
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Treatment with a Vitamin K Antagonist due to having a m 5 2021-10-19
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended

2023-508630-34-00 Overweight 5 2024-05-28
A Study of Dato-DXd With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast C… Ended

2023-505552-22-00 Stage I-III Triple-negative Breast Cancer with residual 5 2023-02-24
Bicarbonate for the treatment of cardiac arrest Ended

2022-501304-10-00 In-hospital cardiac arrest 6 2023-02-06
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f… Ended

2023-507961-24-00 High-Risk HER2-Positive Breast Cancer 5 2021-04-19